United States

Showing 241-250 of 325 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Towards FDA approval of Autonomous AI for diabetic retinopathy screening in youth	Johns Hopkins University	Risa Wolf	Improving Lives	01-January-2023 to 31-December-2025	$637,547.20
Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening	Jaeb Center for Health Research	Adam Glassman	Improving Lives	01-February-2021 to 31-January-2026	$750,000.00
A Phase 2 Study Evaluating Short-Term Efficacy of Tonabersat (Xiflam) for Diabetic Macular Edema	Jaeb Center for Health Research	Adam Glassman	Improving Lives	01-September-2022 to 01-January-2026	$273,424.00
JDRF T1D Coordinating Center	Jaeb Center for Health Research	Judy Sibayan	Transportfolio	01-August-2019 to 31-August-2027	$2,914,531.01
Advanced Preclinical Development of iTOL-101, a Combination Investigational Product Composed of A Biotechnology-Derived Chimeric Streptavidin and A Fas Ligand (SA-FasL) Protein Bound to Biotinylated Hydrogel-Based Microparticles (Microgel) and Mixed with Deceased Donor Human Pancreatic Islets for the Treatment of Poorly-Controlled (or “Brittle”) Type 1 Diabetes	iTolerance, Inc.	Camillo Ricordi	Cures	01-June-2022 to 31-August-2025	$850,000.00
JDRF-IQVIA Adult T1D Detection	IQVIA, Inc.	Nadejda Leavitt	Cures	01-October-2022 to 31-August-2025	$953,780.00
Advancing T1D Detection and Care Through AI	IQVIA, Inc.	Nadejda Leavitt	Cures	01-February-2025 to 31-January-2026	$345,083.00
Adult T1D Detection at Geisinger	IQVIA, Inc.	Nadejda Leavitt	Cures	01-July-2023 to 31-December-2025	$890,727.00
Clinical Translation of T-1123, an Ultra-rapid, Concentrated, Temperature stable Novel Insulin Analog	Invictus Therapeutics, LLC	Robyn Day	Improving Lives	15-October-2025 to 31-May-2027	$1,437,112.00
A smart Semiconductor based Continuous Diabetes Monitoring Platform	Integrated Medical Sensors Inc	Muhammad Mujeeb-U-Rahman	Improving Lives	01-June-2022 to 07-November-2025	$500,000.00